GlaxoSmithKline is the most attractive European healthcare stock in our quant model on equities. But in the short term there is risk of FDA approval of a generic replacement for GSK’s Advair drug around May 10. Because of this tail risk we are playing GSK by buying call options.
Join everyone on Discord!
Trade Stocks, FX, Gold, Oil & More with Bitcoin on 1Broker.uk
Get a Bitcoin MasterCard here to take out your Crypto-profits CASH in ATM-Machines worldwide!